Biomarker analysis of coBRIM: Phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma | Prof Grant McArthur

At the European Cancer Congress (ECC) 2015, Grant McArthur, MBBS, BMedSc, PhD, FRACP, of the Peter MacCallum Cancer Centre, Victoria, Australia, discusses the impact of baseline genetic heterogeneitie... Author: EMJ Added: 11/17/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts